Another "chance" for interferon gamma 1B?

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 28, Issue 1, 2011, Pages 79-80

  Casoni, G L ^a   Chilosi, M ^b   Romagnoli, M ^a   Tomassetti, S ^a   Poletti, Venerino ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA1B INTERFERON; STEROID;

CLINICAL ARTICLE; FIBROSING ALVEOLITIS; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-GAMMA, RECOMBINANT; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME;

EID: 79960460271     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. King TE Jr, Albera C, Bradford WZ, et al. INSPIRE Study Group Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 2009; 374: 222-8.
2. Luppi F, Losi M, D'Amico R, et al. Endogenous blood maximal interferon production may predict response to interferon γ-1 treatment in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2009; 26: 64-8.
3. Reghellin D, Poletti V, Tomassetti S, et al. Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27; 57-63.
4. Ziesche R, Hofbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis N Engl J Med 1999; 341: 1264-9.
5. Barrera L, Mendoza F, Zuniga J, et al. Functional Diversity of T Cell Subpopulations in Subacute and Chronic Hypersensitivity Pneumonitis. Am J Respir Crit Care Med 2008; 177: 44-55.